Enterprise Value
$3.40 B
-$91.40 M-2.62%
5 min ago
Summary
- As of February 7, 2025, CRSP enterprise value is $3.40 billion, with a fall of -$91.40 million (-2.62%) during the most recent trading day.
- Over the past year, CRSP enterprise value has dropped by -$1.72 billion (-33.53%).
- CRSP enterprise value is now -76.40% below its all-time high of $14.42 billion.
Performance
CRSP Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
CRSP Enterprise Value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | -2.6% | -2.6% | -2.6% |
| 1 m1 month | -5.7% | -5.7% | -5.7% |
| 3 m3 months | -23.7% | -23.7% | -23.7% |
| 6 m6 months | -10.1% | -15.8% | -15.9% |
| ytdytd | +1.3% | +1.3% | +1.3% |
| 1 y1 year | -33.5% | -35.5% | -39.5% |
| 5 y5 years | +48.5% | +6.8% | -23.8% |
CRSP Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -10.4% | $3.28 B | +3.7% | |
| 3 m | 3-month | $4.74 B | -28.2% | $3.28 B | +3.7% |
| 6 m | 6-month | $4.74 B | -28.2% | $3.28 B | +3.7% |
| 1 y | 1-year | $7.36 B | -53.8% | $3.28 B | +3.7% |
| 3 y | 3-year | $7.36 B | -53.8% | $2.79 B | +21.8% |
| 5 y | 5-year | $14 B | -76.4% | $1.16 B | +193.5% |
| alltime | all time | $14 B | -76.4% | $256 M | +1229.9% |
CRISPR Therapeutics AG Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $3.40 B(+1.3%) |
| 2024 | $3.36 B(-31.1%) |
| 2023 | $4.88 B(+47.2%) |
| 2022 | $3.31 B(-35.5%) |
| 2021 | $5.14 B(-49.7%) |
| Date | Value |
|---|---|
| 2020 | $10.21 B(+263.2%) |
| 2019 | $2.81 B(+174.3%) |
| 2018 | $1.02 B(+43.7%) |
| 2017 | $713.35 M(+45.8%) |
| 2016 | $489.20 M |
FAQ
- What is CRISPR Therapeutics AG enterprise value?
- What is the all time high enterprise value for CRISPR Therapeutics AG?
- What is CRSP enterprise value year-to-date change?
- What is CRISPR Therapeutics AG enterprise value year-on-year change?
What is CRISPR Therapeutics AG enterprise value?
The current enterprise value of CRSP is $3.40 B
What is the all time high enterprise value for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high enterprise value is $14.42 B
What is CRSP enterprise value year-to-date change?
CRISPR Therapeutics AG enterprise value has changed by +$43.46 M (+1.29%) since the beginning of the year
What is CRISPR Therapeutics AG enterprise value year-on-year change?
Over the past year, CRSP enterprise value has changed by -$1.72 B (-33.53%)